Morgan Stanley’s Prevail Therapeutics Inc. Common Stock PRVL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-21,936
| Closed | -$506K | – | 7710 |
|
|
2020
Q4 | $506K | Sell |
21,936
-619,970
| -97% | -$14.3M | ﹤0.01% | 5074 |
|
|
2020
Q3 | $6.54M | Buy |
641,906
+273,002
| +74% | +$2.78M | ﹤0.01% | 2455 |
|
|
2020
Q2 | $5.5M | Buy |
368,904
+292,096
| +380% | +$4.35M | ﹤0.01% | 2564 |
|
|
2020
Q1 | $937K | Buy |
76,808
+63,847
| +493% | +$779K | ﹤0.01% | 4006 |
|
|
2019
Q4 | $206K | Buy |
12,961
+8,655
| +201% | +$138K | ﹤0.01% | 5401 |
|
|
2019
Q3 | $53K | Sell |
4,306
-8,232
| -66% | -$101K | ﹤0.01% | 5707 |
|
|
2019
Q2 | $166K | Buy |
+12,538
| New | +$166K | ﹤0.01% | 5104 |
|